Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
378.8 USD | -0.63% | +0.03% | +7.12% |
May. 14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
May. 14 | Everest Medicines Commercially Launches Kidney Disease Drug in China | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.12% | 16.57B | |
+19.09% | 64.61B | |
+4.95% | 30.63B | |
+13.85% | 11.83B | |
+8.79% | 2.13B | |
+7.36% | 1.79B | |
+8.32% | 1.01B | |
+41.13% | 651M | |
-18.26% | 597M | |
+14.62% | 460M |
- Stock Market
- Equities
- EG Stock
- News Everest Group, Ltd.
- Chinese Regulator Approves Everest's NDA for Nephropathy Drug